Photo taken from: Thor Halfdanarson / Twitter
Sep 3, 2023, 20:57
Thor Halfdanarson: Trial Alert! ACTION-1 is now open at all three Mayo Clinic sites.
Thor Halfdanarson, GI oncologist with a focus on neuroendocrine tumors (NETs) and Vice President for the North American Neuroendocrine Tumor Society, made the following post on Twitter:
“Trial Alert! ACTION-1 is now open at all three Mayo Clinic sites. Phase III trial of alpha particle PRRT w/ Ac-225 DOTATATE vs. provider’s choice of SOC therapy for pts w/ progressive G1/G2 GEPNETs and prior Lu-177 PRRT. Very simplified schema below.”
For details click here
Source: Thor Halfdanarson / Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 12:13
Nov 13, 2024, 11:52
Nov 13, 2024, 11:48
Nov 13, 2024, 11:44
Nov 13, 2024, 11:39
Nov 13, 2024, 11:30
Nov 13, 2024, 11:25
Nov 13, 2024, 11:10
Nov 13, 2024, 10:59